当前位置:首页 - 行情中心 - 力生制药(002393) - 财务分析 - 现金流量表

力生制药

(002393)

  

流通市值:38.04亿  总市值:39.06亿
流通股本:3.00亿   总股本:3.08亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金818,677,248.43568,558,992.48321,094,641.931,457,801,783.56
  收到的税费返还623,322.7311,048.1130,114.2227,273.83
  收到其他与经营活动有关的现金74,205,283.6747,769,684.6111,159,047.26138,292,035.05
  经营活动现金流入小计893,505,854.83616,339,725.2332,283,803.411,596,121,092.44
  购买商品、接受劳务支付的现金307,909,424.42216,601,515.01107,442,961.56411,270,616.98
  支付给职工以及为职工支付的现金198,761,464.35142,721,209.778,457,393.81280,533,714.05
  支付的各项税费106,574,339.376,639,068.7136,948,912.02190,205,081.14
  支付其他与经营活动有关的现金341,472,541.7224,569,468.25108,445,815.71466,615,029.56
  经营活动现金流出小计954,717,769.77660,531,261.67331,295,083.11,348,624,441.73
  经营活动产生的现金流量净额-61,211,914.94-44,191,536.47988,720.31247,496,650.71
二、投资活动产生的现金流量:
  收回投资收到的现金1,365,749,459.611,070,495,000490,495,0003,110,464,041.67
  取得投资收益收到的现金58,324,260.1746,755,676.213,435,470.13204,356,904
  处置固定资产、无形资产和其他长期资产收回的现金净额60,790.96--2,930,780.89
  投资活动现金流入小计1,424,134,510.741,117,250,676.21493,930,470.133,317,751,726.56
  购建固定资产、无形资产和其他长期资产支付的现金20,847,479.69,658,932.862,756,741.637,459,304.59
  投资支付的现金1,404,634,0001,091,634,000461,634,110.143,440,575,000
  取得子公司及其他营业单位支付的现金---6,991,855
  支付其他与投资活动有关的现金-0-12,500
  投资活动现金流出小计1,425,481,479.61,101,292,932.86464,390,851.743,485,038,659.59
  投资活动产生的现金流量净额-1,346,968.8615,957,743.3529,539,618.39-167,286,933.03
三、筹资活动产生的现金流量:
  吸收投资收到的现金900,000900,000-68,681,900
  取得借款收到的现金---24,314,642.83
  收到其他与筹资活动有关的现金1,085,993.071,085,993.07-1,052,017.97
  筹资活动现金流入平衡项目00-0
  筹资活动现金流入小计1,985,993.071,985,993.07-94,048,560.8
  偿还债务支付的现金25,000,00018,350,000750,00039,750,000
  分配股利、利润或偿付利息支付的现金232,292,483.14231,177,122.7376,759,807.0897,001,999.51
  支付其他与筹资活动有关的现金5,171,098.726,255,425.8-95,433,152.97
  筹资活动现金流出小计262,463,581.86255,782,548.5377,509,807.08232,185,152.48
  筹资活动产生的现金流量净额-260,477,588.79-253,796,555.46-77,509,807.08-138,136,591.68
四、汇率变动对现金及现金等价物的影响----2,566.09
五、现金及现金等价物净增加额-323,036,472.59-282,030,348.58-46,981,468.38-57,929,440.09
  加:期初现金及现金等价物余额1,537,240,303.71,537,235,613.621,537,237,583.641,595,165,053.71
  期末现金及现金等价物余额1,214,203,831.111,255,205,265.041,490,256,115.261,537,235,613.62
补充资料:
  净利润-80,075,919.72-422,726,444.63
  资产减值准备-16,991,227.64-20,080,500.19
  固定资产和投资性房地产折旧-33,105,183.46-67,037,821.49
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-33,105,183.46-67,037,821.49
  无形资产摊销-3,187,290.67-8,270,050.87
  长期待摊费用摊销-366,311.12-651,149.45
  处置固定资产、无形资产和其他长期资产的损失-0--249,613.79
  固定资产报废损失-153,368.19-93,446.42
  公允价值变动损失--1,033,638.05--2,105,592.51
  财务费用-2,089,203.38-2,268,891.66
  投资损失--26,475,341.21--324,770,617.56
  递延所得税----26,190,687.36
  其中:递延所得税资产减少----25,144,691.32
    递延所得税负债增加----1,045,996.04
  存货的减少--18,448,814.37-11,279,585.29
  经营性应收项目的减少--68,888,970.3-78,873,514.42
  经营性应付项目的增加--67,381,328.34--30,470,666.72
  其他---15,866,320.98
  现金的期末余额-1,255,205,265.04-1,537,235,613.62
  减:现金的期初余额-1,537,235,613.62-1,595,165,053.71
  现金及现金等价物的净增加额--282,030,348.58--57,929,440.09
公告日期2026-10-262026-08-212026-04-242026-03-25
审计意见(境内)标准无保留意见
TOP↑